Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve Pursuant to regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Integrated Proteins Ltd has informed BSE that its Board of Directors will meet on Friday, 07 November 2025, to consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended 30 September 2025. The filing is made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements. The trading window for dealing in the company's shares, which has been closed since 1 October 2025, will reopen 48 hours after the results are declared. The intimation is signed by Managing Director Karanj Dharmeshbhai Doshi.
This is a routine regulatory disclosure with no direct impact on the stock price. Investors should watch for the actual Q2 and H1 FY26 results, expected on or shortly after 07 November 2025, to assess the company's financial performance.